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Background: Few studies of the association between psychiatric disorder and premature death have adjusted for
key confounders and used structured psychiatric interviews. We aimed to investigate if psychiatric disorder was
associated with a higher risk of mortality and whether any excess mortality was due to suicide, or explained by
other health or socioeconomic risk factors.
Methods: We used data from the MRC National Survey of Health and Development, a nationally representative UK
birth cohort. 3283 men and women completed the Present State Examination at age 36. The main outcome
measure was all-cause mortality before age 60.
Results: Those with psychiatric disorder at age 36 had a higher risk of death even after adjusting for potential
confounders (Hazard ratio = 1.84, 95% C.I. 1.22-2.78). Censoring violent deaths and suicides led to similar results.
Conclusions: Psychiatric disorder was associated with excess premature mortality not explained by suicide or other
health or socioeconomic risk factors.
Background
Many studies have shown an association between psy-
chiatric disorder and premature death [1-5], mainly from
cardiovascular disease [6-9] and suicide [9-11]. However
negative findings [12,13] have been reported and ques-
tions regarding the degree to which any association may
be accounted for by confounding or mediating factors
remain unresolved [8]. Existing studies have significant
limitations. Few are population-based [8]; follow-up peri-
ods are often short [14,15]; many have relied on subjec-
tive measures of psychiatric disorder [16-18]; and almost
none have controlled for key potential mediating factors,
including physical health status at baseline, tobacco and
alcohol consumption [8]. We therefore have only limited
information on patho-physiological mechanisms by
which psychiatric disorder might lead to higher mortality.
Wulsin suggested the model study to investigate mor-
tality associated with psychiatric disorder would be a pro-
spective cohort design with a large community sample
using structured psychiatric interviews, controlling for
physical health, smoking and alcohol consumption [8].
We present findings from a study meeting all these cri-
teria with the advantages of low attrition and follow-up
over 25 years.
Methods
The Medical Research Council National Survey of
Health and Development (NSHD) is a socially stratified
cohort of 5362 individuals followed up since birth in
England, Scotland and Wales in March 1946. The sam-
pling procedure and follow-up have been described in
detail elsewhere [19]. 3322 (62.0%) were interviewed at
age 36. Of the remaining 2040, 323 (6.0%) had died, 649
(12.1%) had emigrated, 510 (9.5%) had previously
refused to participate and 558 (10.4%) were untraced.
At age 36 research nurses administered the Present State
Examination (PSE) to 3293 participants at home [20]. The
PSE assesses the frequency and severity of psychiatric
symptoms in the preceding month and can be coded as an
index of definition (PSE-ID) which ranges from 1-7. We
distinguish three groups: those with an ID of 3 or more
(22.0%) who typically have at least 5 psychiatric symptoms
and were likely to have a psychiatric disorder; those with
an ID of 2 (30.7%), who were mildly symptomatic with 1-4
symptoms; and those with a PSE-ID of 1 who had no
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based classification system, we determined the presence of
anxiety and depression disorders across PSE-ID categories.
The highest PSE-ID category (PSE-ID= 3 or more) con-
tained all cases of co-morbid depression and anxiety (n =
37), all cases of depression alone (n = 172), and the major-
ity of cases of anxiety alone (n = 362). The remaining
third of anxiety cases (without co-morbid depression) (n =
148) were present in PSE-ID category 2. No cases of anxi-
ety or depression were present in PSE-ID category 1.
3283 of the 3293 men and women with a PSE-ID score
were identified on the National Health Service Central
Register and we were notified of all deaths. The underlying
cause of death was coded according to ICD-9 or ICD-10.
Deaths from “externalizing” disorders including violent
accidental and suicidal deaths (ICD9 codes 291 - 292,
295 - 305, 307 - 309, 311 - 316, 570 - 571.3, 800 - 994,
1800 - 1869, 1880 - 1999 and ICD10 codes F61 - F69, K70
-K 7 1 ,S 0 0-X 9 9 ,Y 8 5-Y 9 8 )w e r ei d e n t i f i e d .
Factors previously found to be associated in this
cohort with premature adult mortality [22-24] were cho-
sen as potential confounders. They included social class
of origin, based on father’s occupation at 4 years, and
own social class at age 26 years, according to the Regis-
trar General’s 1971 classification, dichotomized to man-
ual and non-manual. Childhood cognitive ability was
assessed at age 15 using the Heim AH4 test, [25] the
Watts Vernon reading test, [26] and a mathematics test;
scores were standardised, summed, standardised again
then categorised into fourths. Highest educational quali-
fications at age 26 were categorised into three groups:
no qualifications; Ordinary levels (usually taken at 16);
and Advanced levels (usually taken at 18 for university
entry) or above.
Potential mediating variables were smoking behaviour,
alcohol consumption and physical health status. Current
smokers, ex-smokers and lifelong non-smokers were dis-
tinguished from information collected at adult follow-
ups to age 36 years. Alcohol consumption was recorded
at 36 years using a five day diary; total grams per day
were calculated and categorised into fifths. Physical
health status at age 36 has previously been assessed in
detail [27]. Cohort members were categorised into those
in the best (10.3%), intermediate (62.8%) or in worst
physical health (26.9%), on the basis of measured blood
pressure, lung function and body weight, self reported
health problems and disability, and recent hospital
admissions.
We used survival curves, obtained by the Kaplan-Meier
method, to compare the cumulative death rates between
36 and 60 years for those with and without psychiatric
disorder. Cox’s proportional hazards models were used
to investigate the relationship between psychiatric disor-
der and adult mortality rates. The proportional hazards
assumption was checked using the spthtest function in
Stata. Follow-up time (in months) was from the cohort’s
36
th birthday until the first of death, emigration, or the
end of March 2006. If death had not occurred, follow-up
was treated as censored. Sex adjusted hazard ratios (HRs)
for psychiatric disorder at 36 years were then further
adjusted, in turn, for potential confounders and media-
tors. A further model included all variables. In these
analyses, those with missing data on any potential con-
founder or mediator were assigned to a separate group.
Sensitivity analyses were undertaken to compare the
effects of psychiatric disorder on adult mortality risk, first
including and then excluding this missing category.
We identified 22 cases of schizophrenia in the sample.
All analyses were repeated, censoring for cases of schi-
zophrenia and also censoring for deaths from ‘external’
causes (including accidental deaths and suicide). Ana-
lyses were performed using Stata 10.0 [28]. All results
presented have been weighted to adjust for the social
class stratification in the original sample.
Results
Between 36 and 60 years, 204 cohort members (6.2%)
died. There were more deaths amongst men (7.0%) than
women (5.4%) (p = 0.05). The risk of death was higher
among those with psychiatric disorder (8.1%) and the less
symptomatic (6.7%) compared with those with no symp-
toms (5.0%) (p= 0.01) (Figure 1). In univariate analyses
risk of death was also higher in those whose fathers were
in the manual rather than non-manual social classes or
who were in the manual classes themselves in young
adulthood. Lower childhood cognitive ability at 15 years
and lower educational attainment at age 26 were mod-
estly associated with mortality. Smoking and poor physi-
cal health status but not alcohol consumption was
associated with premature mortality. (Results not shown:
these associations are explored in this cohort in greater
depth in a previous publication [24]).
Table 1 shows the hazard ratios for psychiatric disorder
controlled for each of the potential explanatory factors.
In all analyses there was a strong trend for those scoring
h i g h e ro nt h eP S E - I Dt oh a v eag r e a t e rm o r t a l i t y .T h e
hazard ratio and 95% confidence intervals (CI) for those
with psychiatric disorder was 1.84 (1.22,2.78) and for the
less symptomatic was 1.77 (1.20,2.61) (p = .001). In men
and women, adjusting for father’s social class, attained
social class at age 26 years, IQ or highest educational
attainment made little difference to the hazard ratios. In
men, adjusting for smoking status and alcohol consump-
tion had no effect on the hazard ratios, but adjusting for
physical health status had a modest effect on the hazard
ratio for the group with psychiatric disorder. In women,
adjusting for smoking modestly decreased the hazard
ratio in those with psychiatric disorder. After adjusting
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men and women with psychiatric disorder had a higher
risk death between 36-60 years, and the risk was also
increased in the mildly symptomatic group. A similar
pattern was found when males and females were com-
bined - psychiatric disorder was associated with increased
mortality, and the inclusion of all potential confounders
and mediators only led to a modest reduction in the
effect. Sensitivity analyses which excluded the missing
category from each of the confounders had little effect
either on the hazard ratios for psychiatric disorder or on
the hazard ratios for the categories with valid values. The
only exception was for the model adjusting for alcohol
consumption where the number of missing cases was
considerably greater than for the other confounders or
mediators (see footnote on table 1). The effects of psy-
chiatric disorder were attenuated in this restricted sample
(HR (95%CI) = 1.53 (0.94,2.50) for those with psychiatric
disorder and HR (95%CI) = 1.38 (0.88,2.17) for the less
symptomatic, p=.063).
Table 2 shows that there was hardly any change to the
overall hazard ratio when the thirty deaths from violent,
accidental or suicidal causes were censored in the model.
The hazard ratio for those with psychiatric disorder was
slightly attenuated in men but strengthened in women.
There was also little change to the overall hazard ratio
when the 22 individuals with schizophrenia were excluded.
Discussion
This prospective population-based study showed that
men and women with psychiatric disorder at age 36
have a greater chance of dying before age 60 than those
with no psychiatric disorder. Despite controlling for a
wide range of potential mediators and confounders, the
effect persisted: those with psychiatric disorder had a
mortality risk 84% higher than those with no disorder.
This effect size is in keeping with other studies [2,3].
There was evidence for a trend across severities of psy-
chiatric disorder with milder (and very common) symp-
toms being associated with an intermediate mortality
risk. The association was present across the whole per-
iod of follow up. It is remarkable that an interview on
mood administered just once at age 36 years appears to
impact on mortality more than two decades later, and
indeed the effects sizes associated with psychiatric mor-
bidity are on a par with those shown previously [24] in
t h es a m es a m p l ef o rs m o k i n gs t a t u s .T h ec o n t i n u e d
impact of psychiatric disorder at age 36 on mortality
over mid-life suggests that the effect is not simply
mediated by unmeasured (and uncontrolled) confound-
ing by physical disease at baseline.
This study has a number of methodological strengths.
The NSHD is a representative sample of the post-war
generation born in Britain in 1946 and has a compar-
able pattern for premature adult mortality [29]. There is
little attrition. Participants have been followed up into
late middle age and even at age 53 was still representa-
tive of the national population of a similar age [30]. It
includes detailed measures of psychiatric disorder at age
36. Death was independently confirmed and we have
complete follow-up status on all except those who
emigrated.
Figure 1 Cumulative death rate 36-60 years by PSE-ID categories adjusted for sex.
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measures of socio-demographic status are valid there
may be some misclassification - these are “snapshots” at
one time and may not fully represent the individual’s
background. Our measures of alcohol consumption and
physical health status are taken at age 36 only and
cannot give a ‘whole life exposure’ picture. We were
therefore unable to compare disease incidence rates dur-
ing follow-up for those with and without psychiatric dis-
order which may explain the variation in mortality.
Particular caution is required in interpreting the results
where alcohol consumption was included as a potential
Table 1 Hazard ratios for mortality (36-60 years) by psychiatric disorder at 36 years, obtained from Cox’s proportional
hazards models and based on 3283 men and women and 204 deaths
Hazard ratios (95%CI) Test for trend P value
Male Female All (sex adjusted)
Unadjusted results
Psychiatric disorder - index of definition** 1 1.0 1.0 1.0 <0.001
2 1.66 (1.02, 2.70) 1.92 (1.04, 3.57) 1.75 (1.19, 2.56)
3 - 7 1.84 (1.05, 3.22) 2.24 (1.22, 4.11) 2.00 (1.34, 3.00)
Adjusted for father’s social class at 4 years*
Psychiatric disorder - index of definition** 1 1.0 1.0 1.0 <0.001
2 1.64 (1.01, 2.67) 1.96 (1.05, 3.66) 1.74 (1.19, 2.54)
3 - 7 1.82 (1.04, 3.19) 2.20 (1.20, 4.05) 1.97 (1.32, 2.95)
Adjusted for IQ at 15 years*
Psychiatric disorder - index of definition** 1 1.0 1.0 1.0 <0.001
2 1.67 (1.03, 2.73) 1.97 (1.06, 3.66) 1.78 (1.21, 2.60)
3 - 7 1.80 (1.02, 3.18) 2.26 (1.22, 4.16) 1.99 (1.33, 2.99)
Adjusted for educational qualifications by 26 years*
Psychiatric disorder - index of definition** 1 1.0 1.0 1.0 <0.001
2 1.67 (1.02, 2.73) 1.98 (1.07, 3.66) 1.78 (1.22, 2.62)
3 - 7 1.88 (1.07, 3.29) 2.24 (1.22, 4.11) 2.04 (1.36, 3.06)
Adjusted for social class at 26 years*
Psychiatric disorder - index of definition** 1 1.0 1.0 1.0 <0.001
2 1.71 (1.05, 2.79) 1.97 (1.06, 3.66) 1.80 (1.23, 2.64)
3 - 7 1.93 (1.10, 3.40) 2.20 (1.20, 4.04) 2.04 (1.36, 3.06)
Adjusted for social class, IQ, Education and adult social class at 26 years
Psychiatric disorder - index of definition** 1 1.0 1.0 1.0 <0.001
2 1.70 (1.03, 2.80) 1.95 (1.05, 3.61) 1.80 (1.23, 2.65)
3 - 7 1.86 (1.05, 3.29) 2.11 (1.15, 3.88) 2.00 (1.33, 3.00)
Adjusted for smoking up to 36 years*
Psychiatric disorder - index of definition** 1 1.0 1.0 1.0 0.001
2 1.68 (1.02, 2.76) 1.99 (1.07, 3.69) 1.75 (1.19, 2.56)
3-7 1.81 (1.03, 3.16) 2.01 (1.07, 3.75) 1.90 (1.26, 2.86)
Adjusted for alcohol consumption at 36 years*
Psychiatric disorder - index of definition** 1 1.0 1.0 1.0 <0.001
2 1.68 (1.03, 2.74) 1.90 (1.02, 3.55) 1.75 (1.19, 2.57)
3 - 7 1.93 (1.11, 3.38) 2.20 (1.20, 4.04) 2.02 (1.35, 3.01)
Adjusted for physical health status at 36 years *
Psychiatric disorder - index of definition** 1 1.0 1.0 1.0 0.001
2 1.59 (0.98, 2.58) 1.99 (1.08, 3.65) 1.72 (1.18, 2.51)
3 - 7 1.70 (0.96, 3.01) 2.19 (1.19, 4.01) 1.87 (1.25, 2.81)
Adjusted for all
Psychiatric disorder - index of definition** 1 1.0 1.0 1.0 0.001
2 1.70 (1.02, 2.83) 2.16 (1.15, 4.02) 1.77 (1.20, 2.61)
3 - 7 1.80 (1.01, 3.22) 2.03 (1.09, 3.75) 1.84 (1.22, 2.78)
* missing data for father’s social class (n = 254), IQ at 15 years (n = 462), educational qualifications by 26 years (n = 149), alcohol consumption at 36 years
(n = 864), social class at 26 years (n = 225), smoking up to 36 years (n = 251) and physical health status at 36 years (n-61).
** Index of definition: 1 = no symptoms; 2 = 1-4 symptoms; 3-7 = 5 or more symptoms.
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of psychiatric disorder on mortality risk was somewhat
smaller. This may be due to selection bias in those com-
pleting 5-day diet diaries. We have only included deaths
from age 36 onwards. The role of psychiatric disorders
in the 322 deaths before this is not known although Lee
(2006) has shown in this cohort that high trait anxiety is
associated with reduced risk of accidental death before
36 [31]. There were only 11 suicides amongst the cohort
between the ages of 16 and 50 [32]. Given that we used
only a single measure of psychiatric disorder the hazard
ratio we have calculated probably represents an underes-
timate of the true association between psychiatric disor-
der and mortality.
How might psychiatric disorder increase the risk of
premature death? At least four hypotheses deserve con-
sideration. First, psychiatric disorder might be indirectly
associated with higher mortality via risk behaviours not
analysed here - lower exercise, greater obesity or poor
compliance with medication. There is increasing evi-
dence that patients with severe mental illness receive
less good physical health care than others [33,34]. Sec-
ond, there may be direct biological links whereby immu-
nological or endocrine effects associated with depression
increase the risk of death from cardiovascular disease or
cancer [7,35]. Third, it is possible that the effects
observed relate not to the psychiatric disorders but to
the effects of their treatment, for example diabetes in
patients taking antipsychotic medication [36]. Fourth,
the association between psychiatric disorder and
mortality might represent a common ‘upstream’ cause
such as adverse intrauterine exposures [37] or genetic
pleiotropy [38,39].
Conclusions
Our study has confirmed the increased mortality in
those suffering from psychiatric disorder. Moreover it
has demonstrated that this association cannot be
accounted for by suicide, smoking, alcohol or worse
general physical health although these are important
public health issues in this vulnerable group. We believe
this is the first time that this has been shown in a
cohort containing data on all the major potential con-
founding variables.
Health inequalities are of increasing public health and
policy interest. That psychiatric disorders are associated
with death is insufficiently recognized by patients,
healthcare professionals and policymakers. Our finding
that this is an independent effect only emphasizes the
importance that should be attached to good mental
healthcare. We have highlighted a number of possible
mechanisms to explain this association and further,
more detailed analyses are required to disentangle these
possible pathways and thereby develop potential
interventions.
contributors
MJH, MHH and DK conceived and designed the study.
IS and RH undertook the data analyses. MJH drafted
the manuscript, and MHH, RD and DK critically revised
Table 2 Hazard ratios for mortality (36-60 years) by psychiatric disorder at 36 years, obtained from Cox’s proportional
hazards models and based on 3283 men and women and 204 deaths
Hazard ratios (fully adjusted) (95%CI) Test for trend P value
Male Female All (sex adjusted)
Psychiatric disorder - index of definition**
1 1.0 1.0 1.0 0.001
2 1.70 (1.02, 2.83) 2.16 (1.15, 4.02) 1.77 (1.20, 2.61)
3 - 7 1.80 (1.01, 3.22) 2.03 (1.09, 3.75) 1.84 (1.22, 2.78)
Psychiatric disorder - index of definition** (Excluding schizophrenia cases*)
1 1.0 1.0 1.0 0.002
2 1.74 (1.04, 2.91) 2.20 (1.17, 4.13) 1.81 (1.22, 2.67)
3 - 7 1.78 (0.99, 3.20) 1.98 (1.06, 3.69) 1.81 (1.19, 2.75)
Psychiatric disorder - index of definition** (censoring external causes)
1 1.0 1.0 1.0 0.002
2 1.75 (1.01, 3.03) 2.62 (1.37, 5.02) 1.91 (1.27, 2.90)
3 - 7 1.67 (0.88, 3.16) 2.26 (1.17, 4.36) 1.84 (1.18, 2.86)
Psychiatric disorder - index of definition** (censoring external causes and excluding schizophrenia cases *)
1 1.0 1.0 1.0 0.003
2 1.80 (1.04, 3.12) 2.69 (1.39, 5.18) 1.96 (1.29, 2.98)
3 - 7 1.64 (0.86, 3.13) 2.20 (1.13, 4.31) 1.80 (1.15, 2.82)
*22 cases of schizophrenia (of whom 3 had died) were excluded from model 2 and 4.
** Index of definition: 1 = no symptoms; 2 = 1-4 symptoms; 3-7 = 5 or more symptoms.
Henderson et al. BMC Psychiatry 2011, 11:37
http://www.biomedcentral.com/1471-244X/11/37
Page 5 of 7the manuscript for important intellectual content. All
authors read and approved the final manuscript.
Acknowledgements
Max Henderson is supported by the NIHR Biomedical Research Centre for
Mental Health BRC Nucleus jointly funded by the Guy’s and St Thomas’
Trustees and the South London and Maudsley Trustees. Matthew Hotopf
and Richard Hayes are funded by the NIHR Biomedical Research Centre for
Mental Health at the South London and Maudsley NHS Foundation Trust
and Institute of Psychiatry, King’s College London. Diana Kuh and Imran
Shah are employed by the UK Medical Research Council.
There was no specific funding for this study.
Author details
1Clinical Senior Lecturer in Epidemiological and Occupational Psychiatry
King’s College London, Institute of Psychiatry Department of Psychological
Medicine Weston Education Centre Cutcombe Road London SE5 9RJ UK.
2King’s College London, Institute of Psychiatry Department of Psychological
Medicine Weston Education Centre Cutcombe Road London SE5 9RJ UK.
3MRC National Survey of Health and Development MRC Unit for Lifelong
Health and Ageing33 Bedford Place London WC1B 5JU UK.
Competing interests
All authors declare that they have no competing interests.
Received: 3 December 2010 Accepted: 8 March 2011
Published: 8 March 2011
References
1. Bruce ML, Leaf PJ, Rozal GP, Florio L, Hoff RA: Psychiatric status and 9-year
mortality data in the New Haven Epidemiologic Catchment Area Study.
The American journal of psychiatry 1994, 151(5):716-721.
2. Cuijpers P, Smit F: Excess mortality in depression: a meta-analysis of
community studies. Journal of affective disorders 2002, 72(3):227-236.
3. Joukamaa M, Heliovaara M, Knekt P, Aromaa A, Raitasalo R, Lehtinen V:
Mental disorders and cause-specific mortality. Br J Psychiatry 2001,
179:498-502.
4. Harris EC, Barraclough B: Excess mortality of mental disorder. Br J
Psychiatry 1998, 173:11-53.
5. Parks J, Svendsen D, Singer P, Foti M: Morbidity and Mortality in People
with Serious Mental Illness. Alexandria, VA; 2006.
6. Barth J, Schumacher M, Herrmann-Lingen C: Depression as a risk factor for
mortality in patients with coronary heart disease: a meta-analysis.
Psychosomatic medicine 2004, 66(6):802-813.
7. Carney RM, Freedland KE, Miller GE, Jaffe AS: Depression as a risk factor
for cardiac mortality and morbidity: a review of potential mechanisms.
Journal of psychosomatic research 2002, 53(4):897-902.
8. Wulsin LR, Vaillant GE, Wells VE: A systematic review of the mortality of
depression. Psychosomatic medicine 1999, 61(1):6-17.
9. Mykletun A, Bjerkeset O, Dewey M, Prince M, Overland S, Stewart R:
Anxiety, depression, and cause-specific mortality: the HUNT study.
Psychosomatic medicine 2007, 69(4):323-331.
10. Hiroeh U, Appleby L, Mortensen PB, Dunn G: Death by homicide, suicide,
and other unnatural causes in people with mental illness: a population-
based study. Lancet 2001, 358(9299):2110-2112.
11. Black DW, Winokur G, Nasrallah A: Is death from natural causes still
excessive in psychiatric patients? A follow-up of 1593 patients with
major affective disorder. The Journal of nervous and mental disease 1987,
175(11):674-680.
12. Fredman L, Schoenbach VJ, Kaplan BH, Blazer DG, James SA, Kleinbaum DG,
Yankaskas B: The association between depressive symptoms and
mortality among older participants in the Epidemiologic Catchment
Area-Piedmont Health Survey. Journal of gerontology 1989, 44(4):S149-156.
13. Zonderman AB, Costa PT Jr, McCrae RR: Depression as a risk for cancer
morbidity and mortality in a nationally representative sample. Jama
1989, 262(9):1191-1195.
14. Roach MJ, Connors AF, Dawson NV, Wenger NS, Wu AW, Tsevat J,
Desbiens N, Covinsky KE, Schubert DS: Depressed mood and survival in
seriously ill hospitalized adults. The SUPPORT Investigators. Archives of
internal medicine 1998, 158(4):397-404.
15. Frasure-Smith N, Lesperance F, Talajic M: Depression and 18-month
prognosis after myocardial infarction. Circulation 1995, 91(4):999-1005.
16. Black DW, Warrack G, Winokur G: The Iowa record-linkage study. III. Excess
mortality among patients with ‘functional’ disorders. Archives of general
psychiatry 1985, 42(1):82-88.
17. Weeke A, Juel K, Vaeth M: Cardiovascular death and manic-depressive
psychosis. Journal of affective disorders 1987, 13(3):287-292.
18. Zilber N, Schufman N, Lerner Y: Mortality among psychiatric patients–the
groups at risk. Acta Psychiatr Scand 1989, 79(3):248-256.
19. Wadsworth M, Kuh D, Richards M, Hardy R: Cohort Profile: The 1946
National Birth Cohort (MRC National Survey of Health and
Development). International journal of epidemiology 2006, 35(1):49-54.
20. Wing J, Cooper J, Sartorius N: Measurement and Classification of Psychiatric
Symptoms: An Instruction Manual for the PSE and Catego Program
Cambridge: Cambridge University Press; 1974.
21. Wing JK: The use of the Present State Examination in general population
surveys. Acta psychiatrica Scandinavica 1980, 62(s285):230-240.
22. Kuh D, Hardy R, Langenberg C, Richards M, Wadsworth ME: Mortality in
adults aged 26-54 years related to socioeconomic conditions in
childhood and adulthood: post war birth cohort study. BMJ (Clinical
research ed 2002, 325(7372):1076-1080.
23. Kuh D, Richards M, Hardy R, Butterworth S, Wadsworth ME: Childhood
cognitive ability and deaths up until middle age: a post-war birth cohort
study. International journal of epidemiology 2004, 33(2):408-413.
24. Kuh D, Shah I, Richards M, Mishra G, Wadsworth M, Hardy R: Do childhood
cognitive ability or smoking behaviour explain the influence of lifetime
socio-economic conditions on premature adult mortality in a British
post war birth cohort? Social science & medicine (1982) 2009,
68(9):1565-1573.
25. Heim A: The AH4 group test of intelligence Windsor: NFER-Nelson; 1970.
26. Pigeon D: Details of the fifteen year tests. In All our future. Edited by:
Douglas J, Ross J, Simpson H. London: Davies; 1968.
27. Kuh DJ, Wadsworth ME: Physical health status at 36 years in a British
national birth cohort. Social science & medicine (1982) 1993, 37(7):905-916.
28. Stata Statistical Software: Stata Release 10.0. College Station, TX: Statacorp
LP; 2007.
29. Kuh D, Hardy M, Hotopf M, Lawlor DA, Maughan B, Westendorp R,
Cooper R, Black S, Mishra G: A Review of lifetime risk factors for mortality.
British Actuarial Journal 2009, 15(supplement):17-64.
30. Wadsworth ME, Butterworth SL, Hardy RJ, Kuh DJ, Richards M,
Langenberg C, Hilder WS, Connor M: The life course prospective design:
an example of benefits and problems associated with study longevity.
Social science & medicine (1982) 2003, 57(11):2193-2205.
31. Lee WE, Wadsworth ME, Hotopf M: The protective role of trait anxiety: a
longitudinal cohort study. Psychological medicine 2006, 36(3):345-351.
32. Neeleman J, Wessely S, Wadsworth M: Predictors of suicide, accidental
death, and premature natural death in a general-population birth
cohort. Lancet 1998, 351(9096):93-97.
33. Mitchell AJ, Malone D: Physical health and schizophrenia. Curr Opin
Psychiatry 2006, 19(4):432-437.
34. Mitchell AJ, Malone D, Doebbeling CC: Quality of medical care for people
with and without comorbid mental illness and substance misuse:
systematic review of comparative studies. Br J Psychiatry 2009,
194(6):491-499.
35. Carney RM, Freedland KE: Depression, mortality, and medical morbidity in
patients with coronary heart disease. Biol Psychiatry 2003, 54(3):241-247.
36. Koro CE, Fedder DO, L’Italien GJ, Weiss SS, Magder LS, Kreyenbuhl J,
Revicki DA, Buchanan RW: Assessment of independent effect of
olanzapine and risperidone on risk of diabetes among patients with
schizophrenia: population based nested case-control study. BMJ (Clinical
research ed 2002, 325(7358):243.
37. Barker DJ: Fetal origins of cardiovascular disease. Annals of medicine 1999,
31(Suppl 1):3-6.
38. McCaffery JM, Frasure-Smith N, Dube MP, Theroux P, Rouleau GA, Duan Q,
Lesperance F: Common genetic vulnerability to depressive symptoms
and coronary artery disease: a review and development of candidate
genes related to inflammation and serotonin. Psychosomatic medicine
2006, 68(2):187-200.
Henderson et al. BMC Psychiatry 2011, 11:37
http://www.biomedcentral.com/1471-244X/11/37
Page 6 of 739. Hotopf M, Henderson M, Kuh D: Invited Commentary: Stress and
Mortality. Am J Epidemiol 2008.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-244X/11/37/prepub
doi:10.1186/1471-244X-11-37
Cite this article as: Henderson et al.: Psychiatric disorder in early
adulthood and risk of premature mortality in the 1946 British Birth Cohort.
BMC Psychiatry 2011 11:37.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Henderson et al. BMC Psychiatry 2011, 11:37
http://www.biomedcentral.com/1471-244X/11/37
Page 7 of 7